RAYMOND JAMES & ASSOCIATES - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$2,556,185
-5.4%
165,235
-3.9%
0.00%0.0%
Q2 2023$2,701,890
+15.0%
171,985
+20.6%
0.00%0.0%
Q1 2023$2,349,477
+17.8%
142,565
+11.5%
0.00%0.0%
Q4 2022$1,993,748
+49.5%
127,804
+24.3%
0.00%
+100.0%
Q3 2022$1,334,000
-15.8%
102,855
-8.8%
0.00%
-50.0%
Q2 2022$1,584,000
-16.3%
112,788
-14.7%
0.00%0.0%
Q1 2022$1,893,000
+34.6%
132,226
+28.2%
0.00%
+100.0%
Q4 2021$1,406,000
-61.9%
103,139
-54.3%
0.00%
-66.7%
Q3 2021$3,694,000
-9.7%
225,541
-7.3%
0.00%
-25.0%
Q2 2021$4,093,000
-1.1%
243,172
+7.3%
0.00%0.0%
Q1 2021$4,138,000
-77.5%
226,632
-77.6%
0.00%
-80.0%
Q4 2020$18,390,000
-5.5%
1,010,449
-7.4%
0.02%
-16.7%
Q3 2020$19,464,000
-6.8%
1,091,013
-6.3%
0.02%
-14.3%
Q2 2020$20,887,000
+13.5%
1,164,907
-3.9%
0.03%
-3.4%
Q1 2020$18,402,000
-10.1%
1,212,231
+16.8%
0.03%
+11.5%
Q4 2019$20,471,000
+25.0%
1,037,540
+9.0%
0.03%
+13.0%
Q3 2019$16,377,000
+34.4%
952,130
+38.3%
0.02%
+27.8%
Q2 2019$12,189,000
+19.1%
688,669
+37.1%
0.02%
+12.5%
Q1 2019$10,231,000
+1307.3%
502,244
+1062.8%
0.02%
+1500.0%
Q4 2018$727,00043,1930.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2020
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders